Literature DB >> 25502850

Treatment of osteoporosis: current state of the art.

Irene Hamrick1, Sarina Schrager, Ann Marie Nye.   

Abstract

Osteoporosis can be treated with medications and lifestyle changes, including avoiding a sedentary lifestyle, alcohol, and smoking. We will identify medications that protect against hip fractures in addition to vertebral fractures, and explore new evidence of adverse effects and risks. Bisphosphonates are used as first-line treatment. We will discuss the latest osteoporosis medications, drug interactions, potential bone protective effects of other drug classes, and the evidence of exercise and kyphoplasty.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25502850     DOI： 10.1007/s10354-014-0335-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  127 in total

1.  Characterization of perimenopausal bone loss: a prospective study.

Authors:  R Recker; J Lappe; K Davies; R Heaney
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

Authors:  H Hallström; A Wolk; A Glynn; K Michaëlsson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

3.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.

Authors:  A M Grant; A Avenell; M K Campbell; A M McDonald; G S MacLennan; G C McPherson; F H Anderson; C Cooper; R M Francis; C Donaldson; W J Gillespie; C M Robinson; D J Torgerson; W A Wallace
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

5.  Compliance with osteoporosis medications.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Joel S Finkelstein; Marilyn Arnold; Jennifer M Polinski; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Osteoporosis intervention following distal forearm fractures: a missed opportunity?

Authors:  Maria-Teresa Cuddihy; Sherine E Gabriel; Cynthia S Crowson; Elizabeth J Atkinson; Claudia Tabini; W Michael O'Fallon; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-02-25

7.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

8.  Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.

Authors:  Joel S Finkelstein; Jason J Wyland; Hang Lee; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

9.  Vitamin D intake in the United States.

Authors:  Carolyn Moore; Mary M Murphy; Debra R Keast; Michael F Holick
Journal:  J Am Diet Assoc       Date:  2004-06

10.  Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.

Authors:  M Sinaki; E Itoi; H W Wahner; P Wollan; R Gelzcer; B P Mullan; D A Collins; S F Hodgson
Journal:  Bone       Date:  2002-06       Impact factor: 4.398
View more
  3 in total

1.  The effect of atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (HMG-CoA), on the prevention of osteoporosis in ovariectomized rabbits.

Authors:  Huan Zhou; Yunqiu Xie; Zulqarnain Baloch; Qingping Shi; Qiang Huo; Tao Ma
Journal:  J Bone Miner Metab       Date:  2016-04-27       Impact factor: 2.626

2.  Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis.

Authors:  Yonghui Xie; Xueying Tan; Jian Huang; Hongwei Huang; Ping Zou; Jingbo Hu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Gene co-expression network analysis identifies BRCC3 as a key regulator in osteogenic differentiation of osteoblasts through a β-catenin signaling dependent pathway.

Authors:  Lixiong Cai; Zhiqian Huo; Haiyun Yang; Fengchun He; Zhenglin Cao; Feng Wu; Lianjun Liu; Bingyin Sun
Journal:  Iran J Basic Med Sci       Date:  2019-02       Impact factor: 2.699
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.